↓ Skip to main content

Dove Medical Press

Experience with the once-yearly histrelin (GnRHa) subcutaneous implant in the treatment of central precocious puberty

Overview of attention for article published in Drug Design, Development and Therapy, December 2008
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
8 X users

Citations

dimensions_citation
17 Dimensions